อ้างอิง ของ การติดยาเบ็นโซไดอาเซพีน

  1. ↑ "dependence", ศัพท์บัญญัติอังกฤษ-ไทย, ไทย-อังกฤษ ฉบับราชบัณฑิตยสถาน (คอมพิวเตอร์) รุ่น ๑.๑ ฉบับ ๒๕๔๕, (แพทยศาสตร์) การติดยา
  2. ↑ de Wit, H; Griffiths, RR (June 1991). "Testing the abuse liability of anxiolytic and hypnotic drugs in humans". Drug and Alcohol Dependence. 28 (1): 83–111. doi:10.1016/0376-8716(91)90054-3. PMID 1679388.CS1 maint: uses authors parameter (link)
  3. ↑ Nutt, DJ (1986-01-01). "Benzodiazepine dependence in the clinic: reason for anxiety". Trends Neurosci. 7: 457–460. doi:10.1016/0165-6147(86)90420-7. สืบค้นเมื่อ 2012-12-21.
  4. ↑ Uzun, S; Kozumplik, O; Jakovljević, M; Sedić, B (Mar 2010). "Side effects of treatment with benzodiazepines". Psychiatr Danub. 22 (1): 90–3. PMID 20305598.CS1 maint: uses authors parameter (link)
  5. ↑ O'brien, CP (2005). "Benzodiazepine use, abuse, and dependence". J Clin Psychiatry. 66 (Suppl 2): 28–33. PMID 15762817.
  6. 1 2 3 4 5 6 Allison, C; Pratt, JA (May 2003). "Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence". Pharmacol. Ther. 98 (2): 171–95. doi:10.1016/S0163-7258(03)00029-9. PMID 12725868.CS1 maint: uses authors parameter (link)
  7. 1 2 3 4 5 6 7 Committee on the Review of Medicines (1980-03-29). "Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines". Br Med J. 280 (6218): 910–2. doi:10.1136/bmj.280.6218.910. PMC 1601049. PMID 7388368.
    “...the committee concluded that, on the present available evidence, the true addiction potential of benzodiazepines was low. The number dependent on the benzodiazepines in the UK from 1960 to 1977 has been estimated to be 28 persons. This is equivalent to a dependence rate of 5-10 cases per million patient months.”
  8. 1 2 3 Haddad, P; Deakin, B; Dursun, S (2004-05-27). "Benzodiazepine dependence". Adverse Syndromes and Psychiatric Drugs: A clinical guide. Oxford University Press. pp. 240–252. ISBN 978-0-19-852748-0.CS1 maint: uses authors parameter (link)
  9. ↑ Cloos, JM; Ferreira, V (January 2009). "Current use of benzodiazepines in anxiety disorders". Current Opinion in Psychiatry. 22 (1): 90–95. doi:10.1097/YCO.0b013e32831a473d. PMID 19122540. S2CID 20715355.CS1 maint: uses authors parameter (link)
  10. 1 2 Puri, BK; Tyrer, P (1998-08-28). "Clinical psychopharmacology". Sciences Basic to Psychiatry (2nd ed.). Churchill Livingstone. pp. 155–157. ISBN 978-0-443-05514-0. สืบค้นเมื่อ 2009-07-11.CS1 maint: uses authors parameter (link)
  11. 1 2 3 4 Longo, LP; Johnson, B (April 2000). "Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives". Am Fam Physician. 61 (7): 2121–8. PMID 10779253.CS1 maint: uses authors parameter (link)
  12. 1 2 Khong, E; Sim, MG; Hulse, G (Nov 2004). "Benzodiazepine dependence" (PDF). Aust Fam Physician. 33 (11): 923–6. PMID 15584332.CS1 maint: uses authors parameter (link)
  13. ↑ National Treatment Agency for Substance Misuse (2007). "Drug misuse and dependence - UK guidelines on clinical management" (PDF). United Kingdom: Department of Health. Archived from the original (PDF) on 2012-10-08. สืบค้นเมื่อ 2009-11-30.
  14. 1 2 Marriott, S; Tyrer, P (August 1993). "Benzodiazepine dependence. Avoidance and withdrawal". Drug Safety. 9 (2): 93–103. doi:10.2165/00002018-199309020-00003. PMID 8104417. S2CID 8550990.CS1 maint: uses authors parameter (link)
  15. ↑ Madhusoodanan, S; Bogunovic, OJ (September 2004). "Safety of benzodiazepines in the geriatric population". Expert Opin Drug Saf. 3 (5): 485–93. doi:10.1517/14740338.3.5.485. PMID 15335303. S2CID 32461633.CS1 maint: uses authors parameter (link)
  16. ↑ Baillargeon, L; Landreville, P; Verreault, R; Beauchemin, JP; Grégoire, JP; Morin, CM (November 2003). "Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial" (PDF). CMAJ. 169 (10): 1015–20. PMC 236226. PMID 14609970. Archived from the original (PDF) on 2011-06-09. สืบค้นเมื่อ 2009-07-17.CS1 maint: uses authors parameter (link)
  17. ↑ Vorspan, F; Barré, T; Pariente, A; Montastruc, F; Tournier, M (October 2018). "[Should the duration of treatment be limited using benzodiazepines?]". Presse Med (in French). 47 (10): 892–898. doi:10.1016/j.lpm.2018.10.006. PMID 30454582.CS1 maint: unrecognized language (link)
  18. ↑ Pétursson, H (1994). "The benzodiazepine withdrawal syndrome". Addiction. 89 (11): 1455–9. doi:10.1111/j.1360-0443.1994.tb03743.x. PMID 7841856.
  19. ↑ Galanter, M; Kleber, HD (2008-07-01). The American Psychiatric Publishing Textbook of Substance Abuse Treatment (4th ed.). United States of America: American Psychiatric Publishing Inc. p. 114. ISBN 978-1-58562-276-4.CS1 maint: uses authors parameter (link)
  20. ↑ Ashton, H (2005). "The diagnosis and management of benzodiazepine dependence" (PDF). Current Opinion in Psychiatry. 18 (3): 249–55. doi:10.1097/01.yco.0000165594.60434.84. PMID 16639148. S2CID 1709063. Archived (PDF) from the original on 2010-09-18.
  21. 1 2 Heberlein, A; Bleich, S; Kornhuber, J; Hillemacher, T (Jan 2009). "[Benzodiazepine dependence: causalities and treatment options]". Fortschr Neurol Psychiatr. 77 (1): 7–15. doi:10.1055/s-0028-1100831. PMID 19101875.CS1 maint: uses authors parameter (link)
  22. ↑ Potokar, J; Coupland, N; Wilson, S; Rich, A; Nutt, D (September 1999). "Assessment of GABA(A) benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines". Psychopharmacology. 146 (2): 180–4. doi:10.1007/s002130051104. PMID 10525753. S2CID 31542770. Archived from the original on 2002-01-12.CS1 maint: uses authors parameter (link)
  23. 1 2 Lader Prof; Morgan Prof; Shepherd Prof; Williams Dr P; Skegg Dr; Parish Prof; Tyrer Dr P; Inman Dr; Marks Dr J (Ex-Roche); Harris P (Roche); Hurry T (Wyeth) (1980-10-30 to 1981-04-03). "Benzodiazepine Dependence Medical Research Council headquarters, Closed until 2014 - Opened 2005" (PDF). England: The National Archives. Cite journal requires |journal= (help); Check date values in: |date= (help)
  24. ↑ "Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease". 2009. PMID 19545440. Cite journal requires |journal= (help)
  25. ↑ "Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death". July 1989. PMID 2568579. Cite journal requires |journal= (help)
  26. 1 2 Koff, JM; Pritchard, GA; Greenblatt, DJ; Miller, LG (November 1997). "The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation". Pharmacology. 55 (5): 217–27. doi:10.1159/000139531. PMID 9399331.CS1 maint: uses authors parameter (link)
  27. ↑ Fujita, M; Woods, SW; Verhoeff, NP และคณะ (March 1999). "Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans". Eur. J. Pharmacol. 368 (2–3): 161–72. doi:10.1016/S0014-2999(99)00013-8. PMID 10193652.CS1 maint: uses authors parameter (link)
  28. ↑ "Low-dose diazepam primes motivation for alcohol and alcohol-related semantic networks in problem drinkers". Behavioural Pharmacology. 15 (7): 503–12. 2004. doi:10.1097/00008877-200411000-00006. PMID 15472572. S2CID 23040302.
  29. ↑ Kushner, MG; Abrams, K; Borchardt, C (March 2000). "The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings". Clin Psychol Rev. 20 (2): 149–71. doi:10.1016/S0272-7358(99)00027-6. PMID 10721495.CS1 maint: uses authors parameter (link)
  30. ↑ "GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics". December 2006. PMID 17132386. Cite journal requires |journal= (help)
  31. ↑ "Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia". June 1998. PMID 9640488. Cite journal requires |journal= (help)
  32. ↑ Khanna, JM; Kalant, H; Weiner, J; Shah, G (1992). "Rapid tolerance and cross-tolerance as predictors of chronic tolerance and cross-tolerance". Pharmacol. Biochem. Behav. 41 (2): 355–60. doi:10.1016/0091-3057(92)90110-2. PMID 1574525. S2CID 20059667.CS1 maint: uses authors parameter (link)
  33. ↑ "Assessment of Zopiclone" (PDF). World Health Organisation. Archived (PDF) from the original on 2007-09-27.
  34. ↑ Allan, AM; Baier, LD; Zhang, X (1992). "Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels". J. Pharmacol. Exp. Ther. 261 (2): 395–402. PMID 1374467.CS1 maint: uses authors parameter (link)
  35. ↑ Rooke, KC (1976). "The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice". J Int Med Res. 4 (5): 355–9. doi:10.1177/030006057600400510. PMID 18375. S2CID 23780461.
  36. ↑ Reddy, DS; Rogawski, MA (2000-12-01). "Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself". J Pharmacol Exp Ther. 295 (3): 1241–8. PMID 11082461.CS1 maint: uses authors parameter (link)
  37. ↑ Martin, D; Olsen, RW (2000). GABA in the nervous system: the view at fifty. Philadelphia: Lippincott Williams Wilkins. p. 211. ISBN 978-0-7817-2267-4.CS1 maint: uses authors parameter (link)
  38. ↑ Kroboth, PD; McAuley, JW (1997). "Progesterone: does it affect response to drug?". Psychopharmacol Bull. 33 (2): 297–301. PMID 9230647.CS1 maint: uses authors parameter (link)
  39. ↑ Smith, SS (2004). Neurosteroid effects in the central nervous system: the role of the GABA-A receptor. Boca Raton, Fla.: CRC Press. pp. 144–145. ISBN 978-0-8493-2392-8.
  40. ↑ Rho, JM; Sankar, R; Cavazos, JE (2004). Epilepsy: scientific foundations of clinical practice. New York: M. Dekker. p. 336. ISBN 978-0-8247-5043-5.CS1 maint: uses authors parameter (link)
  41. ↑ Kaltschmidt, C; Kaltschmidt, B; Baeuerle, PA (1995). "Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons". Proc. Natl. Acad. Sci. U.S.A. 92 (21): 9618–22. Bibcode:1995PNAS...92.9618K. doi:10.1073/pnas.92.21.9618. PMC 40853. PMID 7568184.CS1 maint: uses authors parameter (link)
  42. ↑ Humphries, P; Pretorius, E; Naudé, H (2007). "Direct and indirect cellular effects of aspartame on the brain". European Journal of Clinical Nutrition. 62 (4): 451–62. doi:10.1038/sj.ejcn.1602866. ISSN 0954-3007. PMID 17684524.CS1 maint: uses authors parameter (link)
  43. ↑ Herlenius, E; Langercrantz, H (2004). "Development of neurotransmitter systems during critical periods". Exp Neurol. 190: 8–21. doi:10.1016/j.expneurol.2004.03.027. PMID 15498537. S2CID 32373431.
  44. ↑ "Synapses". The Brain from Top to Bottom. McGill University. Archived from the original on 2020-10-17.
  45. 1 2 3 4 5 6 Ashton, Heather (2002). "Benzodiazepines: How They Work and How to Withdraw".
  46. ↑ Brown, TM; Stoudemire (1998). "Chapter 7 Sedative-Hypnotics and Related Agents". Psychiatric side effects of prescription and over-the-counter medications: recognition and management. USA: American Psychiatric Press Inc. pp. 132–133. ISBN 978-0-88048-868-6.
  47. ↑ Wichniak, A; Brunner, H; Ising, M; F, Pedrosa Gil; Holsboer, F; Friess, E (October 2004). "Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression". Psychoneuroendocrinology. 29 (9): 1101–8. doi:10.1016/j.psyneuen.2003.11.004. PMID 15219633. S2CID 12869379.CS1 maint: uses authors parameter (link)
  48. ↑ Biggio, G; Dazzi, L; Biggio, F และคณะ (December 2003). "Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators". Eur Neuropsychopharmacol. 13 (6): 411–23. doi:10.1016/j.euroneuro.2003.08.002. PMID 14636957. S2CID 22248606.CS1 maint: uses authors parameter (link)
  49. ↑ Bateson, AN (2002). "Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal". Curr. Pharm. Des. 8 (1): 5–21. doi:10.2174/1381612023396681. PMID 11812247.
  50. ↑ Follesa, P; Cagetti, E; Mancuso, L และคณะ (August 2001). "Increase in expression of the GABA(A) receptor alpha (4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists". Brain Res. Mol. Brain Res. 92 (1–2): 138–48. doi:10.1016/S0169-328X(01)00164-4. PMID 11483250.CS1 maint: uses authors parameter (link)
  51. 1 2 3 4 5 Polmear, A (2008-03-31). Evidence-Based Diagnosis in Primary Care: Practical Solutions to Common Problems. United Kingdom: Butterworth-Heinemann. pp. 346–347. ISBN 978-0-7506-4910-0.
  52. ↑ ICD-10 (2007). "Chapter V - Mental and behavioural disorders (F00-F99) - Mental and behavioural disorders due to psychoactive substance use, 10-F19)". World Health Organisation. Archived from the original on 2009-07-27.
  53. ↑ Authier, N; Balayssac, D; Sautereau, M; Zangarelli, A; Courty, P; Somogyi, AA; Vennat, B; Llorca, PM; Eschalier, A (Nov 2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Ann Pharm Fr. 67 (6): 408–13. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.CS1 maint: uses authors parameter (link)
  54. ↑ Tyrer, P; Silk, KR, eds. (2008-01-24). "Treatment of sedative-hypnotic dependence". Cambridge Textbook of Effective Treatments in Psychiatry (1st ed.). Cambridge University Press. p. 402. ISBN 978-0-521-84228-0.CS1 maint: uses editors parameter (link)
  55. ↑ Karch, SB (2006-12-20). Drug Abuse Handbook (2nd ed.). United States of America: CRC Press. p. 617. ISBN 978-0-8493-1690-6.
  56. ↑ Casati, A; Sedefov, R; Pfeiffer-Gerschel, T (2012). "Misuse of medicines in the European Union: a systematic review of the literature". Eur Addict Res. 18 (5): 228–45. doi:10.1159/000337028. PMID 22572594.CS1 maint: uses authors parameter (link)
  57. ↑ Authier, N; Balayssac, D; Sautereau, M; Zangarelli, A; Courty, P; Somogyi, AA; Vennat, B; Llorca, PM; Eschalier, A (Nov 2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Ann Pharm Fr. 67 (6): 408–13. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.CS1 maint: uses authors parameter (link)
  58. ↑ Panus, P; Katzung, BG; Jobst, EE; Tinsley, S; Masters, SB; Trevor, AJ (November 2008). "Sedative-hypnotic drugs". Pharmacology for the Physical Therapist (1 ed.). McGraw-Hill Medical. p. 192. ISBN 978-0-07-146043-9.CS1 maint: uses authors parameter (link)
  59. ↑ Tyrer, P; Silk, KR, eds. (2008-01-24). Cambridge Textbook of Effective Treatments in Psychiatry (1st ed.). Cambridge University Press. p. 532. ISBN 978-0-521-84228-0.CS1 maint: uses editors parameter (link)
  60. ↑ Morgan, K; Dixon, S; Mathers, N; Thompson, J; Tomeny, M (February 2004). "Psychological treatment for insomnia in the regulation of long-term hypnotic drug use" (PDF). Health Technol Assess. National Institute for Health Research. 8 (8): iii–iv, 1–68. doi:10.3310/hta8080. PMID 14960254. Archived from the original (PDF) on 2009-11-16. สืบค้นเมื่อ 2009-11-30.CS1 maint: uses authors parameter (link)
  61. ↑ Baillargeon, L; Landreville, P; Verreault, R; Beauchemin, JP; Grégoire, JP; Morin, CM (November 2003). "Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial". CMAJ. 169 (10): 1015–20. PMC 236226. PMID 14609970.CS1 maint: uses authors parameter (link)
  62. ↑ Gosselin, P; Ladouceur, R; Morin, CM; Dugas, MJ; Baillargeon, L (October 2006). "Benzodiazepine discontinuation among adults with GAD: A randomized trial of cognitive-behavioral therapy". J Consult Clin Psychol. 74 (5): 908–19. doi:10.1037/0022-006X.74.5.908. PMID 17032095.CS1 maint: uses authors parameter (link)
  63. ↑ Morgan, JD; Wright, DJ; Chrystyn, H (December 2002). "Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines" (PDF). Pharm World Sci. 24 (6): 231–5. doi:10.1023/A:1021587209529. PMID 12512155. S2CID 12244299.CS1 maint: uses authors parameter (link)
  64. ↑ Stewart, R; Niessen, WJ; Broer, J; Snijders, TA; Haaijer-Ruskamp, FM; Meyboom-De Jong, B (October 2007). "General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application". J Clin Epidemiol. 60 (10): 1076–84. doi:10.1016/j.jclinepi.2006.11.024. PMID 17884604.CS1 maint: uses authors parameter (link)
  65. ↑ Niessen, WJ; Stewart, RE; Broer, J; Haaijer-Ruskamp, FM (February 2005). "Vermindering van gebruik van benzodiazepinen door een brief van de eigen huisarts aan chronische gebruikers" [Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner]. Ned Tijdschr Geneeskd (in Dutch). 149 (7): 356–61. PMID 15751808.CS1 maint: uses authors parameter (link) CS1 maint: unrecognized language (link)
  66. ↑ Faccini, Marco; Leone, Roberto; Opri, Sibilla; Casari, Rebecca; Resentera, Chiara; Morbioli, Laura; Conforti, Anita; Lugoboni, Fabio (October 2016). "Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases". Journal of Psychopharmacology (Oxford, England). 30 (10): 1047–1053. doi:10.1177/0269881116647505. ISSN 1461-7285. PMID 27166362. S2CID 27167585.
  67. ↑ Tamburin, Stefano; Faccini, Marco; Casari, Rebecca; Federico, Angela; Morbioli, Laura; Franchini, Enrica; Bongiovanni, Luigi Giuseppe; Lugoboni, Fabio (October 2017). "Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence". Journal of Psychopharmacology (Oxford, England). 31 (10): 1369–1373. doi:10.1177/0269881117714050. ISSN 1461-7285. PMID 28613124. S2CID 42432213.
  68. ↑ Ashton, CH (1997). "Benzodiazepine Dependency". ใน Baum, A; Newman, S; Weinman, J; West, R; McManus, C (eds.). Cambridge Handbook of Psychology & Medicine. England: Cambridge University Press. pp. 376–80.CS1 maint: uses editors parameter (link)
  69. ↑ Anthierens, S; Habraken, H; Petrovic, M; Christiaens, T (December 2007). "The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives" (PDF). Scand J Prim Health Care. 25 (4): 214–9. doi:10.1080/02813430701726335. PMC 3379762. PMID 18041658.CS1 maint: uses authors parameter (link)
  70. ↑ MI, Granados Menéndez; MA, Salinero Fort; M, Palomo Ancillo; L, Aliaga Gutiérrez; C, García Escalonilla; R, Ortega Orcos (2006). "Adecuacion del uso de las benzodiacepinas zolpidem y zopiclona en problemas atendidos en atencion primaria" [Appropriate use of benzodiazepines zolpidem and zopiclone in diseases attended in primary care]. Aten Primaria (in Spanish). 38 (3): 159–64. doi:10.1157/13090980. PMID 16945275.CS1 maint: uses authors parameter (link) CS1 maint: unrecognized language (link)
  71. ↑ Barthelmé, B; Poirot, Y (November 2008). "Niveau d'anxiété et de dépendance des primoconsommants d'anxiolytiques : une étude de psychométrie" [Anxiety level and addiction to first-time prescriptions of anxiolytics: a psychometric study]. Presse Med [Medical Press] (in French). 37 (11): 1555–60. doi:10.1016/j.lpm.2007.10.019. PMID 18502091.CS1 maint: uses authors parameter (link) CS1 maint: unrecognized language (link)
  72. ↑ Licata, SC; Rowlett, JK (2008). "Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond". Pharmacology Biochemistry and Behavior. 90 (1): 74–89. doi:10.1016/j.pbb.2008.01.001. PMC 2453238. PMID 18295321.CS1 maint: uses authors parameter (link)
  73. ↑ Davies, James; Rae, Todd; Montague, Luke (2017-07-17). "Long-term benzodiazepine and Z-drugs use in the UK: a survey of general practice". British Journal of General Practice. 67 (662): e609–e613. doi:10.3399/bjgp17X691865. PMC 5569740. PMID 28716996.
  74. ↑ Fruensgaard, K (February 1976). "Withdrawal psychosis: a study of 30 consecutive cases". Acta Psychiatr Scand. 53 (2): 105–18. doi:10.1111/j.1600-0447.1976.tb00065.x. PMID 3091. S2CID 1741725.
  75. ↑ Lader, M (1991). "History of benzodiazepine dependence". Journal of Substance Abuse Treatment. 8 (1–2): 53–9. doi:10.1016/0740-5472(91)90027-8. PMID 1675692.
  76. ↑ Lucki, I; Kucharik, RF (1990). "Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam". Psychopharmacology. 102 (3): 350–6. doi:10.1007/BF02244103. PMID 1979180. S2CID 19255446.CS1 maint: uses authors parameter (link)
  77. ↑ Rickels, K; Case, WG; Schweizer, EE; Swenson, C; Fridman, RB (1986). "Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients". Psychopharmacology Bulletin. 22 (2): 407–15. PMID 2877472.CS1 maint: uses authors parameter (link)
  78. ↑ Lader, M (December 1987). "Long-term anxiolytic therapy: the issue of drug withdrawal". The Journal of Clinical Psychiatry. 48: 12–6. PMID 2891684.
  79. ↑ Miura, S; Murasaki, M (March 1992). "The future of 5-HT1A receptor agonists. (Aryl-piperazine derivatives)". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 16 (6): 833–45. doi:10.1016/0278-5846(92)90103-L. PMID 1355301. S2CID 53166083.CS1 maint: uses authors parameter (link)
  80. ↑ Meier, PJ; Ziegler, WH; Neftel, K (1988-03-19). "Benzodiazepine--Praxis und Probleme ihrer Anwendung" [Benzodiazepine--practice and problems of its use]. Schweizerische medizinische Wochenschrift [Swiss Medical Weekly]. 118 (11): 381–92. PMID 3287602.CS1 maint: uses authors parameter (link)
  81. ↑ Tsuji, K; Tajima, O (January 2012). "[Anxiolytic]". Nippon Rinsho (in Japanese). 70 (1): 42–6. PMID 22413490.CS1 maint: uses authors parameter (link) CS1 maint: unrecognized language (link)
  82. ↑ Linden, M; Bär, T; Geiselmann, B (May 1998). "Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions". Psychological Medicine. 28 (3): 721–9. doi:10.1017/S0033291798006734. PMID 9626728.CS1 maint: uses authors parameter (link)
  83. ↑ Tyrer, P (1993). "Benzodiazepine dependence: a shadowy diagnosis". Biochemical Society Symposia. 59: 107–19. PMID 7910738.
  84. ↑ Karch, SB (2006-12-20). Drug Abuse Handbook (2nd ed.). USA: CRC Press. p. 35. ISBN 978-0-8493-1690-6.
  85. ↑ Dièye, AM; Sy, AN; Sy, GY และคณะ (2007). "Prescription des benzodiazepines par les medecins generalistes du prive a Dakar: Enquete sur les connaissances et les attitudes" [Prescription of benzodiazepines by general practitioners in the private sector of Dakar: survey on knowledge and attitudes]. Thérapie (in French). 62 (2): 163–8. doi:10.2515/therapie:2007018. PMID 17582318.CS1 maint: uses authors parameter (link) CS1 maint: unrecognized language (link)
  86. ↑ Dièye, AM; Sylla, M; Ndiaye, A; Ndiaye, M; Sy, GY; Faye, B (June 2006). "Benzodiazepines prescription in Dakar: a study about prescribing habits and knowledge in general practitioners, neurologists and psychiatrists". Fundam Clin Pharmacol. 20 (3): 235–8. doi:10.1111/j.1472-8206.2006.00400.x. PMID 16671957. Archived from the original on 2013-01-05.CS1 maint: uses authors parameter (link)
  87. ↑ Woody, GE; AT, Mc Lellan; O'Brien, CP (1979). "Development of psychiatric illness in drug abusers. Possible role of drug preference". The New England Journal of Medicine. 301 (24): 1310–4. doi:10.1056/NEJM197912133012403. PMID 41182.CS1 maint: uses authors parameter (link)
  88. ↑ Sheehan, MF; Sheehan, DV; Torres, A; Coppola, A; Francis, E (1991). "Snorting benzodiazepines". Am J Drug Alcohol Abuse. 17 (4): 457–68. doi:10.3109/00952999109001605. PMID 1684083.CS1 maint: uses authors parameter (link)
  89. ↑ Wetterling, T; Backhaus, J; Junghanns, K (September 2002). "Sucht im Alter Ein unterschätztes Problem in der klinischen Versorgung älterer Menschen?" [Addiction in the elderly - an underestimated diagnosis in clinical practice?]. Nervenarzt (in German). 73 (9): 861–6. doi:10.1007/s00115-002-1359-3. PMID 12215877. S2CID 13095353.CS1 maint: uses authors parameter (link) CS1 maint: unrecognized language (link)

ใกล้เคียง

การติดเชื้อในระบบทางเดินปัสสาวะ การติดยาเบ็นโซไดอาเซพีน การติดตามด้วยอิเล็กทรอนิกส์ การติดเกม การติดต่อสื่อสารสะท้อนพื้นผิวดวงจันทร์ การติดเชื้อ การติดเชื้อในกระแสเลือดในทารกแรกเกิด การติดเชื้อทางเดินหายใจ การติด การติดตาม (การลูกเสือ)

แหล่งที่มา

WikiPedia: การติดยาเบ็นโซไดอาเซพีน http://www.racgp.org.au/afpbackissues/2004/200410/... http://www.cmaj.ca/cgi/content/full/169/10/1015 http://thebrain.mcgill.ca/flash/a/a_01/a_01_m/a_01... http://www.cell.com/trends/pharmacological-science... http://www.diseasesdatabase.com/ddb29548.htm http://www.emedicine.com/Bztox/topic813255.htm http://www.icd9data.com/getICD9Code.ashx?icd9=304.... http://pdfserve.informaworld.com/491348__783865453... http://www.kluweronline.com/art.pdf?issn=0928-1231... http://www3.interscience.wiley.com/journal/1185531...